Siga Technologies (SIGA) Asset Utilization Ratio (2011 - 2025)
Siga Technologies' (SIGA) quarterly Asset Utilization Ratio came in at 0.74 in Q3 2025, down 17.61% on a YoY basis from 0.9 in Q3 2024, and down 0.94% quarter-over-quarter from 0.74 in Q2 2025.
Analysis
Siga Technologies (SIGA) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Asset Utilization Ratio for 15 consecutive years, with 0.74 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Asset Utilization Ratio fell 17.61% year-over-year to 0.74; the trailing twelve-month figure through Sep 2025 stood at 0.74 (down 17.61% YoY), and the FY2024 full-year result was 0.56, down 10.66% from the prior year.
- Asset Utilization Ratio retreated to 0.74 in Q3 2025 per SIGA's latest filing, from 0.74 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.18 in Q3 2022 and bottomed at 0.23 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 0.69 across 5 years, with a median of 0.7 in 2022.
- The sharpest annual moves came in 2021 and 2023: Asset Utilization Ratio soared 639.2% in 2021, then slumped 80.65% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.76 in 2021, then retreated by 27.29% to 0.55 in 2022, then increased by 22.18% to 0.68 in 2023, then decreased by 6.93% to 0.63 in 2024, then rose by 16.93% to 0.74 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.74, 0.74, and 0.49 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 0.77 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 0.45 |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 0.74 |
| Jun 30, 2025 | 0.74 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.79 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 1.18 |
| Jun 30, 2022 | 0.86 |
| Mar 31, 2022 | 0.70 |
| Dec 31, 2021 | 0.76 |
| Sep 30, 2021 | 0.42 |
| Jun 30, 2021 | 0.70 |
| Mar 31, 2021 | 0.88 |
| Dec 31, 2020 | 0.86 |